These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 29518098)

  • 21. Is Multi-Drug Resistant Tuberculosis More Prevalent in HIV-Infected Patients in Korea?
    Lee S; Lee SH; Mok JH; Lee SJ; Kim KH; Lee JE; Lee SG; Chung JS; Kwak IS
    Yonsei Med J; 2016 Nov; 57(6):1508-10. PubMed ID: 27593882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for poor multidrug-resistant tuberculosis treatment outcomes in Kyiv Oblast, Ukraine.
    Aibana O; Bachmaha M; Krasiuk V; Rybak N; Flanigan TP; Petrenko V; Murray MB
    BMC Infect Dis; 2017 Feb; 17(1):129. PubMed ID: 28173763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment outcomes of MDR-tuberculosis patients in Brazil: a retrospective cohort analysis.
    Bastos ML; Cosme LB; Fregona G; do Prado TN; Bertolde AI; Zandonade E; Sanchez MN; Dalcolmo MP; Kritski A; Trajman A; Maciel ELN
    BMC Infect Dis; 2017 Nov; 17(1):718. PubMed ID: 29137626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.
    Rose PC; Hallbauer UM; Seddon JA; Hesseling AC; Schaaf HS
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1588-93. PubMed ID: 23032215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with unfavorable treatment outcomes among multidrug-resistant tuberculosis patients, Sierra Leone: a cross-sectional secondary data analysis.
    Koroma JA; Elduma AH; Sesay U; Gebru GN
    BMC Infect Dis; 2024 Jun; 24(1):579. PubMed ID: 38862873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential drug-drug interactions between antiretroviral therapy and treatment regimens for multi-drug resistant tuberculosis: Implications for HIV care of MDR-TB co-infected individuals.
    Mukonzo J; Aklillu E; Marconi V; Schinazi RF
    Int J Infect Dis; 2019 Jun; 83():98-101. PubMed ID: 30991140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between antiretroviral therapy and antitubercular drug resistance in TB treatment outcome among Kazakh TB/HIV co-infected patients.
    Mishkin K; Alaei K; Alikeyeva E; Paynter C; Aringazina A; Alaei A
    J Glob Antimicrob Resist; 2018 Sep; 14():104-108. PubMed ID: 29496619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of comprehensive care for children empirically treated for multidrug-resistant tuberculosis in a setting of high HIV prevalence.
    Satti H; McLaughlin MM; Omotayo DB; Keshavjee S; Becerra MC; Mukherjee JS; Seung KJ
    PLoS One; 2012; 7(5):e37114. PubMed ID: 22629356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of tuberculosis patients in the integrated tuberculosis control model in Chongqing, China: a retrospective study.
    Zhang L; Xing W; Zhou J; Zhang R; Cheng Y; Li J; Wang G; Liu S; Li Y
    BMC Infect Dis; 2020 Aug; 20(1):576. PubMed ID: 32758169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High treatment success rate among multidrug-resistant tuberculosis patients in Myanmar, 2012-2014: a retrospective cohort study.
    Thu MK; Kumar AMV; Soe KT; Saw S; Thein S; Mynit Z; Maung HMW; Aung ST
    Trans R Soc Trop Med Hyg; 2017 Sep; 111(9):410-417. PubMed ID: 29351672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology of drug-resistant tuberculosis among children and adolescents in South Africa, 2005-2010.
    Moore BK; Anyalechi E; van der Walt M; Smith S; Erasmus L; Lancaster J; Morris S; Ndjeka N; Ershova J; Ismail N; Burton D; Menzies H
    Int J Tuberc Lung Dis; 2015 Jun; 19(6):663-9. PubMed ID: 25946356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intensive-phase treatment outcomes among hospitalized multidrug-resistant tuberculosis patients: results from a nationwide cohort in Nigeria.
    Oladimeji O; Isaakidis P; Obasanya OJ; Eltayeb O; Khogali M; Van den Bergh R; Kumar AM; Hinderaker SG; Abdurrahman ST; Lawson L; Cuevas LE
    PLoS One; 2014; 9(4):e94393. PubMed ID: 24722139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment and pregnancy outcomes of pregnant women exposed to second-line anti-tuberculosis drugs in South Africa.
    Mokhele I; Jinga N; Berhanu R; Dlamini T; Long L; Evans D
    BMC Pregnancy Childbirth; 2021 Jun; 21(1):453. PubMed ID: 34182944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multidrug-resistant tuberculosis in an HIV-infected girl.
    Shah I; Mohanty S
    Natl Med J India; 2012; 25(4):210-1. PubMed ID: 23278778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tuberculosis, drug use and HIV infection in Central Asia: an urgent need for attention.
    Schluger NW; El-Bassel N; Hermosilla S; Terlikbayeva A; Darisheva M; Aifah A; Galea S
    Drug Alcohol Depend; 2013 Nov; 132 Suppl 1():S32-6. PubMed ID: 23928052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.
    Tabarsi P; Chitsaz E; Tabatabaei V; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Mansouri D; Masjedi MR; Velayati AA
    Am J Ther; 2011 Sep; 18(5):343-9. PubMed ID: 20535008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Programmatic treatment outcomes in HIV-infected and uninfected drug-resistant TB patients in Khayelitsha, South Africa.
    Mohr E; Cox V; Wilkinson L; Moyo S; Hughes J; Daniels J; Muller O; Cox H
    Trans R Soc Trop Med Hyg; 2015 Jul; 109(7):425-32. PubMed ID: 25979526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High mortality among patients hospitalized for drug-resistant tuberculosis with acquired second-line drug resistance and high HIV prevalence.
    Anderson K; Pietersen E; Shepherd BE; Bian A; Dheda K; Warren R; Sterling TR; van der Heijden YF
    HIV Med; 2022 Nov; 23(10):1085-1097. PubMed ID: 35608016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved Survival and Cure Rates With Concurrent Treatment for Multidrug-Resistant Tuberculosis-Human Immunodeficiency Virus Coinfection in South Africa.
    Brust JCM; Shah NS; Mlisana K; Moodley P; Allana S; Campbell A; Johnson BA; Master I; Mthiyane T; Lachman S; Larkan LM; Ning Y; Malik A; Smith JP; Gandhi NR
    Clin Infect Dis; 2018 Apr; 66(8):1246-1253. PubMed ID: 29293906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global trends, regional differences and age distribution for the incidence of HIV and tuberculosis co-infection from 1990 to 2019: results from the global burden of disease study 2019.
    Wang Y; Jing W; Liu J; Liu M
    Infect Dis (Lond); 2022 Nov; 54(11):773-783. PubMed ID: 35801264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.